Drostanolone Enanthate 200 by NovusLabs

• Effective substance: drostanolone enanthate
• Content: 200mg/ml
• Vial: 10ml
• Form: fluid in inject form
• Know under: Masteron, dromostanolone, Drolban, Masteril, drostapex, drostin
• Dosage: 200-600mg once every five or six days.
• Storage: Store in a dry, cool place. Protect from light and children.

 Drostanolone Enanthate 200 (NovusLabs)

Drostanolone Enanthate 200 by NovusLabs is an injectable anabolic-androgenic steroid (AAS) that utilizes the long-acting enanthate ester. It is a derivative of dihydrotestosterone (DHT) and is chemically distinct from the short-ester propionate version due to its significantly longer half-life.

Product Specifications

• Manufacturer: NovusLabs
• Active Ingredient: Drostanolone Enanthate
• Concentration: 200 mg/ml
• Volume: 10 ml vial
• Ester: Enanthate (long-acting)

Pharmacological Profile

Drostanolone enanthate functions as a synthetic agonist of the androgen receptor (AR). While historically utilized in clinical settings to treat breast cancer, it is now primarily used in performance-enhancement contexts.

• Mechanism of Action: As an androgen ester, the enanthate chain allows for a slow, consistent release of drostanolone into the bloodstream. This enables less frequent administration compared to the propionate version, typically requiring injections only once or twice per week.
• Estrogenic Profile: The compound possesses no estrogenic activity . It does not aromatize, and it exhibits anti-estrogenic properties, which help prevent water retention and gynecomastia during use.
• Anabolic/Androgenic Ratio: It is categorized as having moderate anabolic effects. While often cited as having weak androgenic effects in older literature, in a high-dosage performance context, it still functions as a potent androgen.

Clinical and Performance Context

• Physique Enhancement: Because it does not cause water retention, it is highly sought after for cutting cycles to produce a hard and dry muscular appearance.
• Medical History: Its former clinical use in treating metastatic breast cancer highlights its role in modulating hormonal environments. However, its use is largely discontinued in modern medical practice.
• Suitability: While the text notes its suitability for women in historical clinical contexts, users should be aware that the high concentration (200 mg/ml) is specifically engineered for significant performance outcomes and carries a high risk of virilization for female users.

Safety and Usage Considerations

• Administration: Intramuscular injection is required. Users should maintain sterile protocols to avoid injection site infections.
• Side Effects: While it lacks estrogenic side effects, it is not side-effect-free. Potential risks include:
• Androgenic effects: Oily skin, acne, and potential for androgenic alopecia.
• Lipid Impact: Chronic use can negatively impact cholesterol levels (decreased HDL, increased LDL).
• Hormonal Suppression: Like all exogenous androgens, it will suppress natural testosterone production, necessitating a recovery plan.